Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery.
We investigated the effect of postoperative administration of colloids on hemostasis in 45 patients after cardiac surgery. Patients were randomized to receive 15 mL kg(-1) of either 4% albumin, 4% succinylated gelatin, or 6% hydroxyethyl starch (molecular weight of 200 kDa/degree of substitution 0.5) as a short-term infusion. There was a comparable decrease in maximum clot firmness of thromboelastometry tracings in gelatin and hydroxyethyl starch groups immediately after completion of the infusion, whereas these values remained unchanged in the albumin group. The impairment in clot strength persisted up to 2 h, although the values partly recovered. Postoperative bleeding correlated inversely with the clot strength in pooled data of the artificial colloids. Fibrin formation (clot formation time, alpha-angle) and fibrinogen-dependent clot strength (maximum clot firmness and shear elastic modulus) were more disturbed in the hydroxyethyl starch group than in the gelatin group. We conclude that after cardiopulmonary bypass surgery, both gelatin and hydroxyethyl starch impair clot strength and fibrin buildup, which may predispose patients to increased blood loss. The greatest impairment in hemostasis was seen after hydroxyethyl starch administration, whereas albumin appeared to have the least effect on hemostatic variables.
Niemi
Tomi T
TT
Department of Anesthesiology and Intensive Care Medicine, Helsinki University Hospital, Meilahti Hospital, Helsinki, Finland. tomi.niemi@hus.fi
Suojaranta-Ylinen
Raili T
RT
Kukkonen
Sinikka I
SI
Kuitunen
Anne H
AH
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000418:Albumins / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D013504:Cardiovascular Surgical Procedures / Q000379:methods / Q000706:statistics & numerical data*; D016009:Chi-Square Distribution; D005260:Female; D005780:Gelatin / Q000009:adverse effects / Q000494:pharmacology*; D006487:Hemostasis / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects / Q000494:pharmacology*; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D011182:Postoperative Care / Q000379:methods / Q000706:statistics & numerical data; D013386:Succinates / Q000009:adverse effects / Q000494:pharmacology*
D000418:Albumins; D006895:Hydroxyethyl Starch Derivatives; D013386:Succinates; C060085:succinylated gelatin; D005780:Gelatin